Skip to main content
SpringerLink
Log in

Evaluating the Clinical Benefit of Interleukin-2 Plus Antiretroviral Therapy: Is Raising CD4+ Cell Counts Sufficient?

  • Clinical Trial Report
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. The University of Illinois at Chicago, 808 S. Wood Street, MC 735, Chicago, IL, 60612, USA

    Olamide Jarrett

Authors
  1. Olamide Jarrett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olamide Jarrett.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jarrett, O. Evaluating the Clinical Benefit of Interleukin-2 Plus Antiretroviral Therapy: Is Raising CD4+ Cell Counts Sufficient?. Curr HIV/AIDS Rep 7, 1–3 (2010). https://doi.org/10.1007/s11904-009-0032-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-009-0032-x

Keywords

Search

Navigation